The dividend stock set to soar 30%+ by the end of 2018

This company’s shares could be on the cusp of stunning performance.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Buying a turnaround stock can often be a profitable move. Certainly, there is a risk that its comeback will falter, but there is also the potential for high capital gains in the long run. Reporting on Thursday was a stock which has already returned to profitability and is now looking ahead to significant growth. As such, now could be the right time to buy it.

A transitional year

The company in question is RSA Insurance (LSE: RSA). Its results for last year show it has become a strong, organic growth play which is delivering much-improved levels of profitability. For example, group operating profit moved 25% higher, while its underwriting profit of £380m was a record level. It completed the disposals of its businesses in Latin America and Russia, which brings it a step closer to its principal disposal programme of achieving a more concentrated strategic focus.

RSA’s balance sheet and capital ratios provide further evidence of its return to health. Its solvency II coverage ratio of 158% is at the upper end of its 130-160% target, while its reserve margin was strengthened by 50 basis points to 5.5% during the year. It should be relatively well-insulated from the effects of Brexit, since around 70% of its profit is derived from currencies other than sterling.

Outlook

Profit growth of 51% is forecast for the current year, while further growth of 18% is expected next year. RSA could even gain a currency boost from weaker sterling during the two-year period, which would lead to an upgrade to its guidance.

However, even if this does not take place the company’s price-to-earnings growth (PEG) ratio of 0.7 indicates that there is significant upward rerating potential. Even if its shares were to rise by 30%, it would still be trading on a price-to-earnings (P/E) ratio of 16 by the end of next year. Given its potential for double-digit profit growth in the long run, this would not be a particularly demanding valuation. That’s especially the case since RSA is transitioning from a turnaround stock to one which has a sound financial base and a more attractive business model through which to report higher profitability.

This should positively impact on RSA’s dividends. It currently yields 3.4%, but with such strong growth potential and a dividend which is covered twice by profit, a significantly higher yield could be on offer in future years.

Sector Peer

Insurance sector peer Hiscox (LSE: HSX) trades on a P/E ratio of 16.6 at the present time. This is higher than RSA’s rating would be if its shares moved 30% higher and it meets its guidance over the next two years. Even on such a heady P/E ratio, Hiscox does not seem to be overvalued. It is due to report a rise in earnings of 10% in 2018, which puts it on a relatively attractive PEG ratio of 1.6. As such, it appears to be worth buying for the long term.

Hiscox has an excellent track record of growth, with profit rising in each of the last four years. As such, it may be viewed as somewhat lower risk than its sector peer. However, RSA is now a much stronger company than in recent years and seems to have the scope to rise by at least 30%, while offering a yield which is 0.8% higher than that of its sector peer.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »